Patrick Lavery is an Editor for the MJH Life Sciences brands Pharmaceutical Technology and BioPharm International, and their respective websites, pharmtech.com and biopharminternational.com. Previously at MJH, he filled the same role for LCGC International and Spectroscopy.
CHMP Gives Positive Opinion to Novo Nordisk Hemophilia Treatment
October 22nd 2024As many as 30% of people living with severe hemophilia A develop inhibitors such as TFPI, which can be produced by the body’s immune response to clotting factors in replacement therapy, often limiting the effectiveness of that therapy.
AAPS PharmSci 360 2024: The Future of Bioanalysis
October 18th 2024Xiao-Yan Cai, PhD, co-founder and CEO of Accurant Biotech, discussed collaborative efforts that must be undertaken between companies, and across scientific disciplines, to work together on continuing to develop medicines to save lives.
Bormioli Pharma Display at CPHI Milan to Include Low-Impact, Pharma-Grade Product Range
September 26th 2024The EcoPositive range, which comprises 50% of Bormioli Pharma’s current standard catalog and is composed of three distinct sustainability approaches, offers more than 3000 industrial solutions, in glass and plastic.